Ezetimibe and Daptomycin Interaction

Drug interaction information between Ezetimibe and Daptomycin.

Ezetimibe and Daptomycin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Ezetimibe and Daptomycin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ezetimibe

Cholesterol Absorption Inhibitor

Drug B

Daptomycin

Lipopeptide Antibiotic

How They Interact

Both of these medicines can cause muscle damage as a side effect. Taking them together makes this risk even higher and can lead to a serious condition where muscle tissue breaks down.

FDA Label Information

Daptomycin Clinical Impact: Cases of rhabdomyolysis have been reported with simvastatin administered with daptomycin. Both ezetimibe and simvastatin and daptomycin can cause myopathy and rhabdomyolysis when given alone and the risk of myopathy and rhabdomyolysis may be increased by coadministration. Intervention: If treatment with daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during the course of daptomycin treatment.

Frequently Asked Questions

What SPL severity band is on file for Ezetimibe + Daptomycin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ezetimibe has 25 labeled pairs on file vs Daptomycin's 3. In the moderate band specifically: Ezetimibe has 4 (also Colchicine, Niacin, Simvastatin); Daptomycin has 3 (also Ezetimibe/Simvastatin, Simvastatin).

What mechanism field is on file for Ezetimibe and Daptomycin?

Both of these medicines can cause muscle damage as a side effect. Taking them together makes this risk even higher and can lead to a serious condition where muscle tissue breaks down.

Ezetimibe carries more major-labeled pairs than Daptomycin

SPL source-record counts only. This page's band is moderate · classes on file: Ezetimibe (Cholesterol Absorption Inhibitor); Daptomycin (Lipopeptide Antibiotic).

Ezetimibe has 8 major-labeled pairs vs Daptomycin's 0. This page itself is in the moderate band, not the major band.

Ezetimibe

8 major · 4 moderate · 13 minor · 25 total

Daptomycin

0 major · 3 moderate · 0 minor · 3 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.